what was the first glp 1 drug Reflections on discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions How GLP-1 medications are transforming
Description
Regulatory submission for retatrutide is expected in 2026
Pietrzykowska, MD, FACP Spring 2015 Obesity is a serious public health issue
Get more insights with our podcast Gain unique and valuable insights from Wellmark when you listen to our monthly Health Matters podcast
Weighing the infant regularly to confirm adequate growth
GLP-1 use was compared to insulin/metformin or sodium-glucose cotransporter 2 (SGLT2) inhibitors in BC patients with T2D or glycated hemoglobin (HbA1c) 6.5% (T2D cohort), and to non-use in BC patients with obesity (obesity cohort)
Brain glucose metabolism in an animal model of depression
